New app aims to make End-of-Life conversations easier for cancer patients

NCT ID NCT04515810

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a mobile app called PACT that helps people with advanced cancer talk about and plan the care they would want if they couldn't speak for themselves. The app involves patients and their loved ones in these discussions. Researchers want to see if the app is easy to use and if it helps patients take action on advance care planning.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Planning Advance Care Together (PACT) mobile app
What this could lead to
If successful, this app could help more cancer patients discuss and document their care wishes, reducing stress for families and ensuring patients' preferences are respected.
What could go wrong
This is an early feasibility study with 400 participants, so it may not prove the app improves actual care outcomes. The app requires internet access, which may limit use for some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED MALIGNANT SOLID NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    RECRUITING

    Seattle, Washington, 98109, United States

  • Mount Sinai Hospital

    ACTIVE_NOT_RECRUITING

    New York, New York, 10029, United States

  • NYP/Weill Cornell Medical Center

    NOT_YET_RECRUITING

    New York, New York, 10065, United States

  • Northwell Health

    NOT_YET_RECRUITING

    Manhasset, New York, 11030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.